Comparison Keros Therapeutics (KROS) with Competitors
Keros Therapeutics (KROS) industry is Biotechnology.
Profit Margin
KROS-256.60%
Industry-0.77%
Upside-255.83%
Operating Margin
KROS-7051.00%
Industry-2055.25%
Upside-4995.75%
Free Cash Flow Yield
KROS-26.76%
Industry-1.75%
Upside-25.02%
P/E
KROS-3.31
Industry-20.52
Upside+1721.18%
Forward P/E
KROS48.78
Industry16.33
Upside+198.71%
P/S
KROS6.58
Industry10.01
Upside-34.29%
P/B
KROS0.73
Industry5.15
Upside-85.78%